Pablo R. Moya

Affiliations: 
National Institute of Mental Health, Bethesda, MD, United States 
Area:
neuropharmacology, serotonin
Google:
"Pablo Moya"
Mean distance: 36617.1
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Delgado-Acevedo C, Estay SF, Radke AK, et al. (2019) Correction: Behavioral and synaptic alterations relevant to obsessivecompulsive disorder in mice with increased EAAT3 expression. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
Delgado-Acevedo C, Estay SF, Radke A, et al. (2018) Behavioral and synaptic alterations relevant to obsessive-compulsive disorder in mice with increased EAAT3 expression. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
González LF, Henríquez-Belmar F, Delgado-Acevedo C, et al. (2017) Neurochemical and behavioral characterization of neuronal glutamate transporter EAAT3 heterozygous mice. Biological Research. 50: 29
Sotomayor-Zárate R, Jara P, Araos P, et al. (2014) Improving amphetamine therapeutic selectivity: N,N-dimethyl-MTA has dopaminergic effects and does not produce aortic contraction. Basic & Clinical Pharmacology & Toxicology. 114: 395-9
Moya PR, Wendland JR, Rubenstein LM, et al. (2013) Common and rare alleles of the serotonin transporter gene, SLC6A4, associated with Tourette's disorder. Movement Disorders : Official Journal of the Movement Disorder Society. 28: 1263-70
Stewart SE, Mayerfeld C, Arnold PD, et al. (2013) Meta-analysis of association between obsessive-compulsive disorder and the 3' region of neuronal glutamate transporter gene SLC1A1. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 162: 367-79
Murphy DL, Moya PR, Fox MA, et al. (2013) Anxiety and affective disorder comorbidity related to serotonin and other neurotransmitter systems: obsessive-compulsive disorder as an example of overlapping clinical and genetic heterogeneity. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 368: 20120435
Moya PR, Dodman NH, Timpano KR, et al. (2013) Rare missense neuronal cadherin gene (CDH2) variants in specific obsessive-compulsive disorder and Tourette disorder phenotypes. European Journal of Human Genetics : Ejhg. 21: 850-4
Fox MA, Panessiti MG, Moya PR, et al. (2013) Mutations in monoamine oxidase (MAO) genes in mice lead to hypersensitivity to serotonin-enhancing drugs: implications for drug side effects in humans. The Pharmacogenomics Journal. 13: 551-7
Moya PR, Wendland JR, Salemme J, et al. (2013) miR-15a and miR-16 regulate serotonin transporter expression in human placental and rat brain raphe cells. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 16: 621-9
See more...